Type 2 Diabetes Trial, Recruiting (NCT06561126)

Type 2 Diabetes Trial, Recruiting NCT06561126 Sponsor: Khyber Medical University Peshawar Condition: Type 2 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT06561126 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 2 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 20 years of age or older.
People who live in rural areas of Peshawar or Swabi, Pakistan.
People who are willing to take part and agree to give their consent to participate.
People with normal blood sugar levels, borderline high blood sugar, or diagnosed diabetes are all welcome to participate.
People who are able to attend the scheduled meetings and activities as required by the study plan.

Who may not be able to join:

People who are under 20 years of age.
People who are not willing to give their consent to take part in the study.
People who have serious health conditions that may prevent them from taking an active role in the study (confirm with trial site).
People who have a history of not following through with medical treatments or research study requirements.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Prof. Dr Zia Ul Haq, MBBS,MPH,PhD, Khyber Medical Univeristy Peshawar

Phone: +92 333 9258763

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06561126

Sponsor: Khyber Medical University Peshawar

Phase: Not Applicable

Status: Recruiting

Condition: Type 2 Diabetes

Trial contact: +92 333 9258763

More information: https://clinicaltrials.gov/study/NCT06561126

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 20 years of age or older.
People who live in rural areas of Peshawar or Swabi, Pakistan.
People who are willing to take part and agree to give their consent to participate.
People with normal blood sugar levels, borderline high blood sugar, or diagnosed diabetes are all welcome to participate.
People who are able to attend the scheduled meetings and activities as required by the study plan.

Who may not be able to join:

People who are under 20 years of age.
People who are not willing to give their consent to take part in the study.
People who have serious health conditions that may prevent them from taking an active role in the study (confirm with trial site).
People who have a history of not following through with medical treatments or research study requirements.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Khyber Medical University Peshawar

Registry

ClinicalTrials.gov

Start date

1 May 2025

Est. completion

30 May 2026

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Prevalence of Type 2 Diabetes Mellitus; Prevalence of Intermediate Hyperglycemia (IHG); 2-year cumulative incidence of Type 2 Diabetes Mellitus

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov